ArticleJNCI cancer spectrum2018
Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.
Article in JNCI cancer spectrum, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 34 citations in OpenAlex.
- Malignant phyllodes tumor arising from a previously biopsy-proven fibroadenoma: a case report.Journal of surgical case reports · 2026Article
- Reproductive factors and expression of stem cell markers in women with incident benign breast disease.American journal of cancer research · 2024Article
- Review
- A Comprehensive Review of Breast Fibroadenoma: Correlating Clinical and Pathological Findings.Cureus · 2023Review
- Increased Risk of Breast Fibroadenomas Among Obese and Postmenopausal Women With Uterine Fibroids.Cureus · 2023Article
- Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets.Nature communications · 2023Article
- An integrated radiomics nomogram based on conventional ultrasound improves discriminability between fibroadenoma and pure mucinous carcinoma in breast.Frontiers in oncology · 2023Article
- The Risk of Antipsychotic Drugs on Breast Cancer: A Systematic Review and Meta-analysis.Oman medical journal · 2022Review
- Prevalence of breast fibroadenoma in healthy physical examination population in Guangdong province of China: a cross-sectional study.BMJ open · 2022Article
- Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study.International journal of cancer · 2021Article
- Association analyses of a genetic variant in long non-coding RNA MEG3 with breast cancer susceptibility and serum MEG3 expression level in the Egyptian population.Cancer biomarkers : section A of Disease markers · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo understand which breast cancer (BC) risk factors also increase the risk of fibroadenoma and investigate whether these factors have the same effect in BC patients with previous fibroadenoma.
methodsUsing multistate survival analysis on a large dataset (n
resultsThe mean ages at diagnosis of fibroadenoma and BC were 42.6 and 48.3 years, respectively. Participant characteristics known to increase the risk of BC were found to increase the risk of fibroadenoma (family history of BC and higher education). Participant characteristics known to confer protective effects for BC (older age at menarche, more children, and larger childhood body size) were found to reduce fibroadenoma risk. The effect sizes associated with the direct transitions from event-free to fibroadenoma and BC were generally not different for the covariates tested. Age at fibroadenoma diagnosis was associated with the transition from fibroadenoma to BC (hazard ratio
conclusionWe showed that biopsy-confirmed fibroadenomas shared many risk factors with BC. More work is needed to understand the relationships between fibroadenoma and BC to identify women who are at high risk of developing BC after a fibroadenoma diagnosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.